no covid confirmation no pneumonia previous treatment with any of the study drugs concomitant serious medical condition: congestive heart failure acute myocardial infarction 6 months prior unstable angina cardiomyopathy unstable ventricular arrhythmia uncontrolled hypertension uncontrolled psychotic disorders serious active infections hiv infections active hepatitis neoplasia in active cancer treatment inability to take oral medication or malabsorption syndrome saw. inability to comply with study and follow-up procedures history of only relevant thromboembolic or hemorrhagic episodes in the last 6 months contraindication to any study medication pregnant women

no covid confirmation no pneumonia previous treatment with any of the study drugs concomitant serious medical condition: congestive heart failure acute myocardial infarction 6 months prior unstable angina cardiomyopathy unstable ventricular arrhythmia uncontrolled hypertension uncontrolled psychotic disorders serious active infections hiv infections active hepatitis neoplasia in active cancer treatment inability to take oral medication or malabsorption syndrome saw. inability to comply with study and follow-up procedures history of only relevant thromboembolic or hemorrhagic episodes in the last 6 months contraindication to any study medication pregnant women

- no covid confirmation - no pneumonia - previous treatment with any of the study drugs - concomitant serious medical condition: 1. congestive heart failure 2. acute myocardial infarction 6 months prior 3. unstable angina 4. cardiomyopathy 5. unstable ventricular arrhythmia 6. uncontrolled hypertension 7. uncontrolled psychotic disorders 8. serious active infections 9. hiv infections 10. active hepatitis 11. neoplasia in active cancer treatment - inability to take oral medication or malabsorption syndrome saw. - inability to comply with study and follow-up procedures - history of only relevant thromboembolic or hemorrhagic episodes in the last 6 months - contraindication to any study medication - pregnant women

- no covid confirmation - no pneumonia - previous treatment with any of the study drugs - concomitant serious medical condition: 1. congestive heart failure 2. acute myocardial infarction 6 months prior 3. unstable angina 4. cardiomyopathy 5. unstable ventricular arrhythmia 6. uncontrolled hypertension 7. uncontrolled psychotic disorders 8. serious active infections 9. hiv infections 10. active hepatitis 11. neoplasia in active cancer treatment - inability to take oral medication or malabsorption syndrome saw. - inability to comply with study and follow-up procedures - history of only relevant thromboembolic or hemorrhagic episodes in the last 6 months - contraindication to any study medication - pregnant women